3-(3-fluorophenyl)-4'-methoxypropiophenone, 97.0%, 1g

1-Butanol, min. 99.5%, for synthesis, 10 l, tinplate

1-(3-Chloropyridin-4-yl)piperazine trihydrochloride, 1g

anti-Keratin K20 mouse monoclonal, IT-Ks20.8, 1 ml

3-Azepan-1-yl-propylamine, 95.0%, 5g

2-(3-((3-Methoxybenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 1g

2-Bromo-5-ethoxypyrazine, 95.0%, 100mg

2,2'-Dihydroxy-1H,1'H-[2,2'-biindene]-1,1',3,3'(2H,2'H)-tetraone dihydrate, 97%, 250mg

6-Methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine hydrochloride, 98%, 250mg

2-Phenylcyclopropanamine, 90.0%, 1g

3-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline, 97.0%, 25g

Diiodomethane (stabilized with Copper chip)>98.0%(GC)25g

6-IODO-2-OXASPIRO[3.3]HEPTANE, 95.0%, 10g